AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Apriglave MV 2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Dwivsonchem Life Science

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Apriglave MV 2 Tablet ER

Glimepiride-Metformin extended-release tablets are categorized as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication as prescribed, even with controlled blood sugar, as discontinuation without medical guidance can elevate blood glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to identify hypoglycemia symptoms, such as sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and always carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain is a possible consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnancy or breastfeeding necessitates prior consultation with your doctor. Regular blood glucose monitoring is essential, and your physician may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Apriglave MV 2 Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Apriglave MV 2 Tablet ER

Managing type 2 diabetes

Major Benefits of Apriglave MV 2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Apriglave MV 2 Extended-Release tablets should be taken on an empty stomach.

Common Side effects of Apriglave MV 2 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Apriglave MV 2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglave MV 2 Tablet ER. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.

How Apriglave MV 2 Tablet ER works:

Apriglave MV 2 Extended-Release tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Apriglave MV 2 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Apriglave MV 2 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. Your physician will assess the potential advantages against any risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Apriglave MV 2 tablets are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Extended-release Apriglave MV 2 tablets are likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is necessary. Furthermore, their use is discouraged in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Exercise caution when prescribing Apriglave MV 2 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Initiate treatment with a reduced Apriglave MV 2 Tablet ER dosage in patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in those with severe hepatic disease.

What if you forget to take Apriglave MV 2 Tablet ER :

Should you forget to take an Apriglave MV 2 Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Apriglave MV 2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Apriglave MV 2 Tablet ER

Apriglave MV 2 Tablet ER combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Apriglave MV 2 Tablet ER may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Apriglave MV 2 Tablet ER is contraindicated in patients allergic to its components or excipients, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Apriglave MV 2 Tablet ER and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Apriglave MV 2 Tablet ER can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly sealed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Apriglave MV 2 Tablet ER
121
MRP 140
13% off